ライフサイエンスコーパス: adjust

1 400th case in the volume-outcome model, risk-adjusted adverse outcomes declined, including mortality

2 80; P = 0.003) for eyes of children with age-adjusted ALD < -1 mm (myopic).

3 7.9% v 3.5%, P = .039) and a reduced risk in adjusted analyses (odds ratio, 0.41; 95% CI, 0.171 to 0.

4 In adjusted analyses, bystander CPR was associated with a r

5 of IIH, yielding an overall age- and gender-adjusted annual incidence of 1.8 per 100 000 (95% confid

6 suggesting that it was the only method that adjusted appropriately for the marked effect of BCG-attr

7 nt conditions.SIGNIFICANCE STATEMENT Animals adjust behavior in response to environmental changes, su

8 owever, the content of trace elements can be adjusted by cultivation conditions.

9 CI, 25%-51%); the disease-specific survival adjusted by eye cancer center was better in patients who

10 When adjusted by operator, a multivariate model showed increa

11 We found that by adjusting certain parameters, albeit within their biolog

12 The adjusted change in mean estimated glomerular filtration

13 er death was generated and compared with age-adjusted Charlson Comorbidity Index (CCI) by using the H

14 channels (KATP channels) in cardiac myocytes adjust contractile function to compensate for the level

15 c melding employs an algorithm that globally adjusts contrasts amongst the 2D tiles so as to produce

16 neurons have distinct sets of mechanisms for adjusting coupling according to the specific type of act

17 We examined all-cause mortality using adjusted Cox models.

18 he AD subtype of dementia, separately, using adjusted Cox proportional hazards models.

19 patient outcomes between 1994 and 2012 using adjusted Cox regression models.

20 7%) of 4430 children in the control schools (adjusted difference 50%, 95% CI 44-55).

21 group and 2.16 points in the placebo group (adjusted difference, -0.20; 95% CI, -0.40 to 0.00; P = .

22 od culture use decreased from 14.5% to 4.9% (adjusted difference, -7.7%; 95% CI, -13.1% to -2.4%).

23 relation between hospitals' observed or risk-adjusted DTN and D2B times.

24 Adjusted effect estimates for conditional mortality were

25 153) failed to show noninferiority of GSH-I (adjusted effect, 1.47; 95% CI, -0.01 to 2.91; P = .05).

26 Our adjusted estimate for maternal GBS colonization worldwid

27 been limited.We examine whether inflammation-adjusted ferritin and sTfR concentrations affect TBI val

28 iron deficiency (defined as an inflammation-adjusted ferritin concentration <12 mug/L).

29 Analyses were performed to adjust for age, sex, educational level, history of skin

30 surveillance; however, these studies did not adjust for confounders and therefore were not designed t

31 ighted logistic regression model was used to adjust for confounders.

32 The studies appeared to adequately adjust for confounding.

33 Depending on the approach used to adjust for inflammation (CRP plus AGP), the estimated pr

34 Depending on the approach used to adjust for inflammation (CRP+AGP), the estimated prevale

35 proportional hazards regression was used to adjust for potential confounding by a wide range of fact

36 alysis of Coordinated Expression" (GRACE) to adjust for the effect of SCNA in co-expression analysis.

37 and Carrier Estimation Algorithm) software, adjusted for age at baseline data collection.

38 ssessed with Cox proportional hazards models adjusted for age, sex, AMD severity, VA, history of cata

39 hazard ratio [aHR], 1.28; 95% CI, 1.13-1.46) adjusted for age, sex, and race.

40 er (HR, 1.56; 95% CI, 1.06-2.30; P = 0.024), adjusted for age, sex, and statistically significant cov

41 nsonism per SD decrease in global cognition, adjusted for age, sex, and study subcohort.

42 P values were adjusted for age, sex, carotid artery site, and family r

43 tiple brain regions were compared by ANCOVA, adjusted for age.

44 accommodate for serial autocorrelation, and adjusted for any potential effect of birth seasonality o

45 re randomly assigned to "control" (FIO2 0.3, adjusted for arterial oxygen saturation >/= 90%) and "hy

46 red patients with standardized protocols and adjusted for baseline characteristics by Cox regression.

47 ted conditional logistic regression analyses adjusted for body mass index, smoking, hypertension, dia

48 When adjusted for bronchopulmonary dysplasia, the difference

49 atio [aOR] 0.83, 95% CI 0.70-0.99; I(2)=51%, adjusted for CD4 cell count and ART duration), and there

50 used to estimate odds ratios (ORs) that were adjusted for comorbidity, education level, and income le

51 nd 95% confidence intervals using Cox models adjusted for confounders.

52 ehavior, self-esteem and depressive symptoms adjusted for infant characteristics (sex, gestational ag

53 Costs were adjusted for inflation and reported in 2015 dollars.

54 Multiple linear regression models adjusted for potential confounders were used to estimate

55 Analyses were adjusted for potential confounders.

56 mated using Cox proportional hazards models, adjusted for potential confounders.

57 When the FCAT test scores were adjusted for potentially confounding maternal and infant

58 sion every 8 h) for 7-14 days; regimens were adjusted for renal function.

59 oning test scores using linear mixed models, adjusted for sex and education, and meta-analytic techni

60 ional hazards and flexible parametric models adjusted for stratification factors.

61 esults were confirmed in regression analysis adjusted for team composition.

62 el in which the impact of each covariate was adjusted for that of all others.

63 ime to readmission or death within 12 months adjusted for the number of previous COPD admissions, pre

64 ing polynomial terms in spatial error models adjusted for total population and population density.

65 ltivariate Cox proportional hazard modeling, adjusted for treatment, patient age, year of diagnosis,

66 Models then considered the effect of adjusting for 15 common haematology and biochemistry tes

67 After adjusting for age, initial Glasgow Coma Scale, and mean

68 constructed a Cox proportional hazards model adjusting for age, sex, race, and comorbidity.

69 these differences were not significant after adjusting for age.

70 also observed at lower CD4 cell counts after adjusting for age.

71 regression analysis to compare SMC with GES, adjusting for baseline and stratification factors.

72 tients with PAD compared with those without, adjusting for baseline characteristics and postprocedure

73 survival for black and white patients after adjusting for baseline characteristics.

74 the association of SGA birth with adiposity, adjusting for baseline covariates only, and 2) made addi

75 s (CIs) from Cox proportional hazards models adjusting for baseline prognostic factors.

76 ncentivised group using logistic regression, adjusting for community and number of children as fixed

77 1; 95% confidence interval, 1.08-2.10) after adjusting for confounders.

78 a/skin allergy in the first 6 years of life, adjusting for confounders.

79 After adjusting for confounding factors using a generalized li

80 Following multivariate analyses adjusting for covariates IL6, interleukin 1beta (IL1beta

81 litation facility (3.6% vs. 2.5%, P <0.001), adjusting for covariates.

82 o determine the volume-outcome relationship, adjusting for demographic (sex, age, race, ethnicity), s

83 d from multilevel logistic regression model, adjusting for demographics, mechanism, vital signs, and

84 CSF tau levels with postmortem tau pathology adjusting for demographics.

85 hese associations remained significant after adjusting for dietary fibre intake.

86 Not adjusting for dilution, standardizing or adjusting for u

87 Adjusting for farm type (broiler vs. layer), the odds of

88 After adjusting for inflation, the decline in funding to denta

89 justed risk ratios (aRRs) and 95% CIs, after adjusting for maternal age, country of origin, education

90 g multivariate logistic regression analyses, adjusting for maternal age, ethnicity, birth country and

91 ancy and severe mental illness in offspring, adjusting for measured covariates and unmeasured confoun

92 markers that were modestly poorer even after adjusting for medical comorbidity, including increased r

93 Similar findings were obtained by adjusting for motor disability (P < .05, permutation-cor

94 te any genotype-treatment interactions after adjusting for multiple testing.

95 5 (95% confidence interval, 1.70-2.99) after adjusting for other risk factors.

96 ociated with lower discharge GOS score after adjusting for patient age, gender and histological brain

97 After adjusting for patient variables and the correlation betw

98 e databases, and we determined the impact of adjusting for potential confounders collected from a sub

99 ific mortality by low-dose aspirin use after adjusting for potential confounders.

100 ls (CIs) for FI risk in women receiving MHT, adjusting for potential confounding factors.

101 ever, in models that compared siblings while adjusting for pregnancy, maternal, and paternal traits,

102 We constructed multivariable models adjusting for PSA, Gleason sum, number of prior hormone

103 g performance and environmental stimulation, adjusting for resident characteristics (i.e., age, gende

104 Conditional logistic regression models adjusting for risk factors evaluated associations betwee

105 or levofloxacin) use and patient mortality, adjusting for risk factors typically associated with poo

106 Net surge capacity, estimated by adjusting for routine emergency department admissions, w

107 ificant climate dependence (p < 0.001) after adjusting for socioeconomic factors.

108 mating equations and evaluated the impact of adjusting for surveillance within Cox proportional hazar

109 herapy dose was not associated with DFS when adjusting for the (18)F-FMISO status.

110 ge (60-64, 65-69, 70-75 y) and APOE-e4 dose, adjusting for the competing risk of mortality, and deter

111 emisinin-piperaquine treatment failure after adjusting for the presence of amplified plasmepsin II/II

112 Not adjusting for dilution, standardizing or adjusting for urinary flow rate, and using covariate-adj

113 owever, these associations disappeared after adjusting for vascular risk factors (HR = 1.07 [0.98-1.1

114 ons, and vitamin D pathway genetic variants, adjusting for years in education.

115 d and adulthood have been based on analyses "adjusting" for height, weight, or body mass index (BMI;

116 for supraspinal and sensory afferent signals adjusting gait.

117 short-term treatment at week 12, the placebo-adjusted geometric mean ratio of UACR change from baseli

118 Covariate-adjusted geometric means for the sum of the 4 TFAs were

119 cted before treatment was associated with an adjusted hazard ratio (aHR) for treatment failure of 20.

120 invasive breast cancer among those with AF (adjusted hazard ratio (HR) = 1.19, 95% confidence interv

121 te between observed BMI and AF (age- and sex-adjusted hazard ratio 1.05 [1.04-1.06] per kg/m(2), P<0.

122 sociated with a 28% higher risk of dementia (adjusted hazard ratio [aHR], 1.28; 95% CI, 1.13-1.46) ad

123 reased for patients with metastatic disease (adjusted hazard ratio [AHR], 2.3; 95% CI, 1.0 to 5.1; P

124 adverse cardiovascular events (multivariable adjusted hazard ratio [HR(adj)]=0.75, 95% CI 0.66-0.85,

125 rugs (sDMARDs) had the highest risk of HBVr (adjusted hazard ratio [HR] = 5.14; 95% confidence interv

126 The adjusted hazard ratio for acute rejection and all-cause

127 received RVD alone (50 months vs. 36 months; adjusted hazard ratio for disease progression or death,

128 The adjusted hazard ratio for publication was 1.79 (95% conf

129 experienced AKI Network stage 2 or 3 had an adjusted hazard ratio for the primary composite outcome

130 nce x renal replacement therapy interaction (adjusted hazard ratio range, 0.43-0.89; p < 0.001).

131 ted with higher mortality throughout 1-year (adjusted hazard ratio range, 1.30-1.92; p < 0.001), whic

132 ist compared with those aged 18 to 24 years (adjusted hazard ratio, 0-5 years = 0.36; 6-11 = 0.29; 12

133 reduction in the hazard of death after LVAD (adjusted hazard ratio, 0.73; 95% confidence interval, 0.

134 ce infection at 5 years relative to capping (adjusted hazard ratio, 0.78; 95% CI, 0.62-0.97; P=0.027)

135 imilar mortality rates compared with whites (adjusted hazard ratio, 0.92; 95% CI, 0.76-1.11 and adjus

136 ed hazard ratio, 0.92; 95% CI, 0.76-1.11 and adjusted hazard ratio, 0.92; 95% CI, 0.76-1.12, respecti

137 However, the risk of hospitalization (adjusted hazard ratio, 1.34; 95% confidence interval, 1.

138 h NSVT runs at a rate >200 beats per minute (adjusted hazard ratio, 15.63; 95% confidence interval, 4

139 ith an increased rate of ILD-specific death (adjusted hazard ratio, 2.3; 95% confidence interval, 1.7

140 nterval, 4.01-60.89; P<0.0001) and >7 beats (adjusted hazard ratio, 6.26; 95% confidence interval, 2.

141 th Vmax >/=5 m/s had greater mortality risk (adjusted hazard ratio=1.86 [1.55-2.54]; P<0.001), even i

142 en in the subgroup of asymptomatic patients (adjusted hazard ratio=2.08 [1.25-3.46]; P=0.005).

143 For SPK transplantation, low (adjusted hazard ration [aHR], 1.55, 95% confidence inter

144 ness-death model was applied to estimate the adjusted hazard ratios (HRs) for 3 health transitions (h

145 antly higher graft failure risks than males (adjusted hazard ratios 0-14 years: 1.51 [95% confidence

146 onal hazard models to calculate multivariate-adjusted hazard ratios and 95% confidence intervals (CIs

147 to 64 years of age in ARIC and REGARDS, age-adjusted hazard ratios comparing blacks versus whites we

148 en TIL values and progression-free survival (adjusted HR 0.95, 95% CI 0.90-1.00, p=0.063).

149 fat increased the hazard of relapse by 56% (adjusted HR 1.56, 95% CI 1.05 to 2.31, p=0.027), and in

150 The multi-adjusted HR associated with increased risk of RD was 12.

151 Results The multivariable-adjusted HR for death was 1.37 (95% CI, 1.11 to 1.69) co

152 om the DDFs than sentinel hospitals, with an adjusted HR of 3.3 (95% CI: 2.3, 4.6).

153 .5%-88.4%) for women with no pregnancy) (age-adjusted HR, 0.22; 95% CI, 0.10-0.49; P < .001).

154 after diagnosis of esophageal cancer (pooled adjusted HR, 1.03; 95% CI, 0.85-1.25) or gastric cancer

155 95% CI, 0.85-1.25) or gastric cancer (pooled adjusted HR, 1.06; 95% CI, 0.85-1.32).

156 sepsis than nonsepsis individuals (0-1 year adjusted HR, 3.12 [95% CI, 1.35-7.23]; 1-4 years, 3.29 [

157 ove the median derived the greatest benefit (adjusted HR: 0.599; 95% CI: 0.530 to 0.677; p < 0.0001).

158 crease in saturated fat tripled this hazard (adjusted HR: 3.37, 95% CI 1.34 to 8.43, p=0.009).

159 The adjusted HRs for living donor KT were 0.35 (95% CI, 0.24

160 had no reduction in mortality with the ICD (adjusted ICD HR: 0.921; 95% CI: 0.787 to 1.08; p = 0.31)

161 f the bundle was associated with higher risk-adjusted in-hospital mortality (odds ratio, 1.04 per hou

162 hage patients had significantly greater risk-adjusted in-hospital mortality (odds ratio, 1.89 [95% CI

163 Risk-adjusted in-hospital mortality declined slightly in the

164 s cases to estimate 2004-2013 trends in risk-adjusted in-hospital sepsis mortality rates by race/ethn

165 The age-adjusted incidence of CMCs was not correlated with bevac

166 The outcome of interest was the age-adjusted incidence of HPV-related cancer (both cervical

167 ll outcomes (e.g., for earache or infection, adjusted incidence rate ratio (IRR) = 1.86, 95% confiden

168 % (from 358 to 332 per 100 000 person-years; adjusted incidence ratio 0.93, 95% CI 0.91-0.94).

169 (renal pelvis, ureter, and bladder cancers: adjusted IRR 2.2, 95% CI 0.9-5.4; N = 89 cases).

170 lem is the mechanism by which a brain region adjusts its activity according to the influence it recei

171 sensitive to their offspring's demands, and adjust levels of care accordingly.

172 S$94 (95% CrI: US$51, US$166) per Disability Adjusted Life Year (DALY) averted, PMI-funded interventi

173 ios (ICERs) in 2015 U.S. dollars per quality-adjusted life year (QALY) gained and number of fragility

174 cost-effectiveness ratios (cost per quality-adjusted life year gained) from the societal perspective

175 $5459 per year, to reach $100000 per quality-adjusted life year.

176 Corresponding increases in survival, quality-adjusted life years (QALYs), costs, and resulting budget

177 Quality-adjusted life years (QALYs), total cost, disease progres

178 redible interval 12 662-132 452) per quality-adjusted life-year (QALY) gained, pound372 207 (268 162-

179 uality-adjusted life-year to $150000/quality-adjusted life-year range frequently cited as cost-effect

180 n in this trial is within the $50000/quality-adjusted life-year to $150000/quality-adjusted life-year

181 plus PCSK9i therapy was $337729 per quality-adjusted life-year.

182 Outcome Measures: Incremental costs, quality-adjusted life-years (QALYs), and incremental cost-effect

183 Quality-adjusted life-years (QALYs), total costs (in US dollars

184 rage lifetime costs, life-years, and quality-adjusted life-years (QALYs).

185 ca will probably lose 2.3 million disability-adjusted life-years and US$3.5 billion of economic produ

186 Benefits were measured in quality-adjusted life-years gained.

187 Changes in quality-adjusted life-years were assessed with utilities determi

188 ources, and impact on health status (quality-adjusted life-years).

189 strain, and e' velocity using multivariable-adjusted linear mixed-effects models (to account for rel

190 Results from age- and race/ethnicity-adjusted linear regression analyses indicated modest, bu

191 We suggest that AhR may serve to adjust liver repair and to block tumorigenesis by modula

192 The adjusted mean change from baseline in body weight in the

193 PPT also produced larger adjusted mean differences, before vs after treatment, in

194 ts [95% confidence interval (CI) 2.8%-15.6%; adjusted means $26,604 vs $24,263; P = 0.005), 12.4% lon

195 4% longer length of stay (95% CI 2.3%-23.5%; adjusted means 5.9 vs 5.2 days; P = 0.015), more complic

196 h a decrease from 14.9 to 14.1 with placebo (adjusted median difference between the cannabidiol group

197 40.4%]; mean (SD) age, 9.9 [1.5] years), the adjusted median number of trigger pulls among children w

198 tunable attenuator (DTA), can automatically adjust MIM operation to retain detector sensitivity when

199 By using parameter estimates from an adjusted model, a prognostic index for prediction of non

200 In the adjusted model, central obesity (OR = 1.88, 95%CI = 1.18

201 r tanning was associated with sunburn in the adjusted model: 82.3% (95% CI, 77.9%-86.0%) of indoor ta

202 In fully adjusted models, only death-censored graft loss remained

203 In adjusted models, we observed significant positive associ

204 when surveillance was removed from otherwise adjusted models.

205 d statistically significant in multivariable adjusted models.

206 cost increases over time, and the inflation-adjusted monthly costs rose since approval by 49% and 44

207 Adjusted mortality rates slightly declined over the stud

208 reestanding pediatric hospitals, annual risk-adjusted mortality rates were calculated for sites betwe

209 til completion of the 3-hour bundle and risk-adjusted mortality.

210 37-5.33), with no unusual variation from the adjusted national incidence of 3.13% (2.85-3.42), despit

211 rn before a gestational age of 32 weeks, the adjusted network incidence of necrotising enterocolitis

212 Complex CHD was associated with greater adjusted odds of serious ventricular arrhythmias (OR, 31

213 k difference = 4.1% [95% CI, -1.4% to 9.6%]; adjusted odds ratio = 0.61 [95% CI, 0.31 to 1.21]; P = .

214 s 42 [49%] of 86 participants, respectively, adjusted odds ratio [aOR] 0.46, 95% CI 0.23-0.89; p=0.02

215 of high-risk HPV than did those not on ART (adjusted odds ratio [aOR] 0.83, 95% CI 0.70-0.99; I(2)=5

216 children attained minimum dietary diversity (adjusted odds ratio [aOR] for women 1.39, 95% CI 1.03-1.

217 least one blood pressure-lowering medicine (adjusted odds ratio [OR] 2.23, 95% CI 1.59-3.12); p<0.00

218 worse 3-month modified Rankin Scale scores: adjusted odds ratio for the fifth quintile versus first

219 y day 28 after adjustment for 16 covariates (adjusted odds ratio, 1.77; 95% CI, 1.17 to 2.68); death

220 , including increased reliance on gait aids (adjusted odds ratio, 1.9; 95% CI, 1.4-2.6); no functiona

221 ldren who saw the movie not containing guns (adjusted odds ratio, 22.3; 95% CI, 6.0-83.4; P < .001).

222 ed variability of nevus dermoscopic pattern (adjusted odds ratio, 4.24; 95% CI, 1.36-13.25; P = .01)

223 ariate analysis, baseline total nevus count (adjusted odds ratio, 9.08; 95% CI, 4.0-23.7; P < .001) a

224 ession model was constructed to quantify the adjusted odds ratios (aORs) of the exposure to PM10 and

225 tic regression analysis was used to estimate adjusted odds ratios (ORs) and 95% confidence intervals

226 Adjusted odds ratios (ORs) were calculated for each coho

227 pital death among patients aged 18-49 years (adjusted odds ratios [aOR] = 0.21; 95% confidence interv

228 Crude and adjusted odds ratios and corresponding 95% CIs were esti

229 omen with previous cesarean deliveries, with adjusted odds ratios of 1.16 (95% CI, 0.98-1.37) for 1 c

230 Adjusted odds ratios were calculated using multivariable

231 f acute pancreatitis, compared to non-users, adjusted OR 0 .

232 with the exception of daily tobacco smoking (adjusted OR 1.74, 95% CI 1.08-2.81), any illicit drug us

233 T (absolute difference in mRS 0-2 of 22% and adjusted OR 4.9, 95% CI 1.2 to 19.7, p=0.021).

234 of both atopy and "any allergic condition" (adjusted OR AOR, 95% CI, 0.54; 0.32-0.92, P = .02, and .

235 d a VKA: 3.6% of cases and 1.1% of controls; adjusted OR, 4.00 [95% CI, 3.40-4.70]; clopidogrel and a

236 a VKA: 0.3% of cases and 0.04% of controls; adjusted OR, 7.93 [95% CI, 4.49-14.02]).

237 nization, and breastfeeding were associated (adjusted P < .05) with disease severity.

238 es C using tri-distilled water without salt, adjusted pH of 5.4 and a flow rate of 0.36mL/min.

239 A risk-adjusted Poisson model evaluated the ratio of observed t

240 The age-/sex-adjusted population attributable risk for these Simple 7

241 eport never/rare use of protective clothing (adjusted prevalence ratio [aPR], 1.28; 95% CI, 1.10-1.49

242 Adjusted prevalence risk ratios (adjPRR) of detectable H

243 sition in pHapo conveys functionality by (i) adjusting protein abundances and (ii) affecting the rheo

244 es-specific toxicity with similar precision; adjusted R(2) and R(2) values ranged from 0.56 to 0.86 a

245 missions (odds ratio 1.57; 95% CI 1.08-2.29; adjusted rates 10% vs 6%; P = 0.018), and no difference

246 ications (odds ratio 1.36; 95% CI 1.04-1.78; adjusted rates 20% vs 16%; P = 0.023), more readmissions

247 Adjusted rates of hospitalization for AF increased by ap

248 l, and treatment characteristics to estimate adjusted rates.

249 s after discharge, (2) time required for the adjusted readmission risk to approach plateau periods of

250 We calculated the (1) time required for adjusted rehospitalization/mortality risks to decline 50

251 k hair vs. red or blonde hair, multivariable-adjusted relative risk (RR) = 0.99, 95% confidence inter

252 of use compared with <1 year, multivariable-adjusted relative risk = 1.09, 95% confidence interval:

253 of use compared with <1 year, multivariable-adjusted relative risk = 1.10, 95% confidence interval:

254 urvival with favorable neurological outcome (adjusted relative risk, 1.6; 95% confidence interval, 1.

255 dren (62%) and was associated with survival (adjusted relative risk, 1.7; 95% confidence interval, 1.

256 We determined the age- and sex-adjusted risk of death for each type of synucleinopathy,

257 al abscess rate decreased from 0.24 to 0.10 (adjusted risk ratio 0.44, 95% confidence interval [CI] 0

258 ened patients to be diagnosed with melanoma (adjusted risk ratio [RR], 2.4; 95% CI, 1.7-3.4; P < .001

259 n log-linear regression was used to estimate adjusted risk ratios (aRRs) and 95% CIs, after adjusting

260 Cohort-specific crude and adjusted risk ratios for asthma at ages 5-9 years were c

261 ollow-up in the Bruneck Study, multivariable adjusted risk ratios per one-SD higher log miR-122 were

262 l day-to-day change, and (3) extent to which adjusted risks are greater among recently hospitalized p

263 lity (for dark tan vs. no tan, multivariable-adjusted RR = 0.98, 95% CI: 0.92, 1.05), skin reaction t

264 otype (for type IV vs. type I, multivariable-adjusted RR = 0.99, 95% CI: 0.92, 1.05).

265 s vs. practically no reaction, multivariable-adjusted RR = 1.01, 95% CI: 0.93, 1.08), or Fitzpatrick

266 The adjusted RR of HO-CDI for hospitals that both experience

267 73) or whose tumors did have KRAS mutations (adjusted RR, 0.59; 95% CI 0.35-1.03; P = .062; P = .90 f

268 whose tumors did not contain KRAS mutations (adjusted RR, 0.81; 95% CI, 0.56-1.18; P = .273) or whose

269 he risk of offspring obesity at ages 6-11 y (adjusted RR: 2.39; 95% CI: 1.97, 2.89) and 12-19 y (adju

270 d RR: 2.39; 95% CI: 1.97, 2.89) and 12-19 y (adjusted RR: 2.74; 95% CI: 2.13, 3.52).

271 ociation, was the prespecified, multiplicity-adjusted secondary outcome.

272 ng perceived staffing and resource adequacy, adjusted staffing, leadership ability and level of impli

273 g for urinary flow rate, and using covariate-adjusted standardization resulted in null associations o

274 ry to photosynthetic carbon flux and in turn adjusts stomatal conductance, photosynthetic CO2 and pho

275 Adjusted survival remained significantly better across t

276 In 2013, age-adjusted TBI mortality was 12.99 per 100,000 population

277 Unadjusted and adjusted temporal trends for the PTOS and NTDB showed in

278 Photosynthetic organisms rapidly adjust the capture, transfer and utilization of light en

279 atively few genes, but this is sufficient to adjust the configuration of the respirome to allow the o

280 We adjusted the concentration of monocarboxylic acid ligand

281 After indicating their choice, participants adjusted the setting of a clock to the moment they felt

282 yPAD can be tuned for optimal performance by adjusting the applied voltage or changing the electrode

283 control the plasma-driven fluid dynamics by adjusting the axial offset of the two focal points.

284 lanes into a single, large 2D image and (iv) adjusting the contrast.

285 g, and the array periodicity can be tuned by adjusting the growth conditions.

286 mal expansion in open-framework materials by adjusting the presence of guests.

287 By adjusting the viscosity of the polymer, the orientation

288 Animals adjust their behavioral priorities according to momentar

289 When flying or swimming, animals must adjust their own movement to compensate for displacement

290 aviour, social plasticity (i.e., individuals adjusting their behaviour), niche preference (i.e., indi

291 owever, whether resting astrocyte Ca(2+) can adjust to a new steady-state level, with an impact on su

292 successful in helping this susceptible group adjust to adult life.

293 Cells adjust to hypoxic stress within the tumor microenvironme

294 fe-years (QALYs), total costs (in US dollars adjusted to 2015-year values using the Consumer Price In

295 ophysiology for these diseases, with therapy adjusted to disease stage.

296 demonstrate how the residual valency can be adjusted to one or two biotin binding sites per immobili

297 Adjusted TO rates varied from 38% to 89% (EVAR) and from

298 ) in VCF placement rates over time; however, adjusted trends showed a slight but significant increase

299 The adjusted VE against A(H1N1)pdm09 was 43% (95% confidence

300 or self-reported measles, the unadjusted and adjusted VE was 67% (40%-82%) and 43% (-12%-71%), respec